BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26927977)

  • 1. Modulating Enzyme Catalysis through Mutations Designed to Alter Rapid Protein Dynamics.
    Zoi I; Suarez J; Antoniou D; Cameron SA; Schramm VL; Schwartz SD
    J Am Chem Soc; 2016 Mar; 138(10):3403-9. PubMed ID: 26927977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isotope-specific and amino acid-specific heavy atom substitutions alter barrier crossing in human purine nucleoside phosphorylase.
    Suarez J; Schramm VL
    Proc Natl Acad Sci U S A; 2015 Sep; 112(36):11247-51. PubMed ID: 26305965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic-site design for inverse heavy-enzyme isotope effects in human purine nucleoside phosphorylase.
    Harijan RK; Zoi I; Antoniou D; Schwartz SD; Schramm VL
    Proc Natl Acad Sci U S A; 2017 Jun; 114(25):6456-6461. PubMed ID: 28584087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse enzyme isotope effects in human purine nucleoside phosphorylase with heavy asparagine labels.
    Harijan RK; Zoi I; Antoniou D; Schwartz SD; Schramm VL
    Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6209-E6216. PubMed ID: 29915028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Femtosecond dynamics coupled to chemical barrier crossing in a Born-Oppenheimer enzyme.
    Silva RG; Murkin AS; Schramm VL
    Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18661-5. PubMed ID: 22065757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purine nucleoside phosphorylase. 1. Structure-function studies.
    Erion MD; Takabayashi K; Smith HB; Kessi J; Wagner S; Hönger S; Shames SL; Ealick SE
    Biochemistry; 1997 Sep; 36(39):11725-34. PubMed ID: 9305962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote mutations alter transition-state structure of human purine nucleoside phosphorylase.
    Luo M; Li L; Schramm VL
    Biochemistry; 2008 Feb; 47(8):2565-76. PubMed ID: 18281957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered thermodynamics from remote mutations altering human toward bovine purine nucleoside phosphorylase.
    Ghanem M; Li L; Wing C; Schramm VL
    Biochemistry; 2008 Feb; 47(8):2559-64. PubMed ID: 18281956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine nucleoside phosphorylase. 3. Reversal of purine base specificity by site-directed mutagenesis.
    Stoeckler JD; Poirot AF; Smith RM; Parks RE; Ealick SE; Takabayashi K; Erion MD
    Biochemistry; 1997 Sep; 36(39):11749-56. PubMed ID: 9305964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic transition states and dynamic motion in barrier crossing.
    Schwartz SD; Schramm VL
    Nat Chem Biol; 2009 Aug; 5(8):551-8. PubMed ID: 19620996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic site conformations in human PNP by 19F-NMR and crystallography.
    Suarez J; Haapalainen AM; Cahill SM; Ho MC; Yan F; Almo SC; Schramm VL
    Chem Biol; 2013 Feb; 20(2):212-22. PubMed ID: 23438750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purine nucleoside phosphorylase. 2. Catalytic mechanism.
    Erion MD; Stoeckler JD; Guida WC; Walter RL; Ealick SE
    Biochemistry; 1997 Sep; 36(39):11735-48. PubMed ID: 9305963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of calf spleen purine nucleoside phosphorylase with two full trimers in the asymmetric unit: important implications for the mechanism of catalysis.
    Bzowska A; Koellner G; Wielgus-Kutrowska B; Stroh A; Raszewski G; Holý A; Steiner T; Frank J
    J Mol Biol; 2004 Sep; 342(3):1015-32. PubMed ID: 15342253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass Modulation of Protein Dynamics Associated with Barrier Crossing in Purine Nucleoside Phosphorylase.
    Antoniou D; Ge X; Schramm VL; Schwartz SD
    J Phys Chem Lett; 2012 Dec; 3(23):3538-3544. PubMed ID: 24496053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural determinants of the 5'-methylthioinosine specificity of Plasmodium purine nucleoside phosphorylase.
    Donaldson TM; Ting LM; Zhan C; Shi W; Zheng R; Almo SC; Kim K
    PLoS One; 2014; 9(1):e84384. PubMed ID: 24416224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition state structure of purine nucleoside phosphorylase and principles of atomic motion in enzymatic catalysis.
    Fedorov A; Shi W; Kicska G; Fedorov E; Tyler PC; Furneaux RH; Hanson JC; Gainsford GJ; Larese JZ; Schramm VL; Almo SC
    Biochemistry; 2001 Jan; 40(4):853-60. PubMed ID: 11170405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tryptophan-free human PNP reveals catalytic site interactions.
    Ghanem M; Saen-oon S; Zhadin N; Wing C; Cahill SM; Schwartz SD; Callender R; Schramm VL
    Biochemistry; 2008 Mar; 47(10):3202-15. PubMed ID: 18269249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the purine nucleoside phosphorylase (PNP) from Cellulomonas sp. and its implication for the mechanism of trimeric PNPs.
    Tebbe J; Bzowska A; Wielgus-Kutrowska B; Schröder W; Kazimierczuk Z; Shugar D; Saenger W; Koellner G
    J Mol Biol; 1999 Dec; 294(5):1239-55. PubMed ID: 10600382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the catalytic mechanism of Escherichia coli purine nucleoside phosphorylase by structural and kinetic studies.
    Mikleušević G; Stefanić Z; Narczyk M; Wielgus-Kutrowska B; Bzowska A; Luić M
    Biochimie; 2011 Sep; 93(9):1610-22. PubMed ID: 21672603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition and structure of Toxoplasma gondii purine nucleoside phosphorylase.
    Donaldson TM; Cassera MB; Ho MC; Zhan C; Merino EF; Evans GB; Tyler PC; Almo SC; Schramm VL; Kim K
    Eukaryot Cell; 2014 May; 13(5):572-9. PubMed ID: 24585883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.